Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment
Official abstract: The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to develop hetIL-15 in combination with other agents, such as PPARa agonists (Fenofibrate), FLT3 inhibitors (quizartinib), IL-12, or chemotherapy into a therapeutic for cancer.